SAN ANTONIO – Austin-based digital health company Everlywell announced it would start to offer the public an at-home collection kit with telehealth diagnosis for COVID-19 starting Monday.
The company said it plans to have testing and diagnosis capacity for 250,000 people weekly.
Recommended Videos
Everlywell had announced it was offering a $1 million development incentive to any certified laboratories that fulfilled requirements set by the U.S. Food and Drug Administration and the company to “prioritize development of a COVID-19 diagnostic test.”
The company said the positive response allowed it to build the at-home collection kit and diagnosis experience for COVID-19.
“Our team has been working around the clock with top scientists and laboratories in the nation to develop a test that we will make available at the lowest price possible while covering our costs, at no profit to the company. We have also reached out to government and public health officials to explore possibilities to provide it for free,” said Julia Cheek, founder and CEO of Everlywell, in a statement.
The company said the test can be requested online by people who are experiencing COVID-19 symptoms. It said the testing kit will be shipped to customers with everything needed to collect a sample at home and ship the sample to a certified lab.
Click here to learn more about the testing kit.
COVID-19, the respiratory disease caused by the new virus, stands for coronavirus disease 2019. The disease first appeared in late 2019 in Wuhan, China, but spread around the world in early 2020, causing the World Health Organization to declare a pandemic in March.
MORE CORONAVIRUS COVERAGE FROM KSAT:
